Block listing Interim Review

Dr. Martens PLC
01 June 2023
 

BLOCK LISTING SIX MONTHLY RETURN

 

Information provided on this form must be typed or printed electronically and provided to an ris.

 

(Note: Italicised terms have the same meaning as given in the Listing Rules.)

Date: 1 JUNE 2023

 

Name of applicant:

DR. MARTENS PLC

Name of scheme:

DR. MARTENS PLC'S EMPLOYEE SHARE PLANS

Period of return:

From:

1 JANUARY 2023

To:

31 MAY 2023

Balance of unallotted securities under scheme(s) from previous return:

469,101 SHARES

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

0 SHARES

Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

103,372 SHARES

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

365,729 SHARES

 






 

Name of contact:

PAUL ROLLING

ASSISTANT COMPANY SECRETARY

Telephone number of contact:

+447584243562

 

 

 

 

 

 

 

 

BLOCK LISTING SIX MONTHLY RETURN

 

Information provided on this form must be typed or printed electronically and provided to an ris.

 

(Note: Italicised terms have the same meaning as given in the Listing Rules.)

Date: 1 JUNE 2023

 

Name of applicant:

DR. MARTENS PLC

Name of scheme:

DR. MARTENS PLC'S EMPLOYEE SHARE PLANS

Period of return:

From:

2 OCTOBER 2022

To:

31 DECEMBER 2022

Balance of unallotted securities under scheme(s) from previous return:

642,502 SHARES

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

0 SHARES

Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

173,401 SHARES

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

469,101 SHARES






 

Name of contact:

PAUL ROLLING

ASSISTANT COMPANY SECRETARY

Telephone number of contact:

+447584243562

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 

Companies

Dr. Martens (DOCS)
UK 100

Latest directors dealings